John Gunn - Dodge & Cox
Holding/activity history for BioMarin Pharmaceutical Inc. (BMRN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 14,561,759 | 0.45 | Reduce 0.07% | <0.01 | $56.49 | $822,593,766 | SEC |
| 2025 Q4 | 14,572,384 | 0.47 | Reduce 0.78% | <0.01 | $59.43 | $866,036,781 | SEC |
| 2025 Q3 | 14,686,801 | 0.43 | Reduce 2.79% | 0.01 | $54.16 | $795,437,142 | SEC |
| 2025 Q2 | 15,108,310 | 0.47 | Add 1.02% | <0.01 | $54.97 | $830,503,801 | SEC |
| 2025 Q1 | 14,955,240 | 0.60 | Add 1.42% | <0.01 | $70.69 | $1,057,185,916 | SEC |
| 2024 Q4 | 14,746,235 | 0.56 | Add 6.10% | 0.03 | $65.73 | $969,270,027 | SEC |
| 2024 Q3 | 13,898,318 | 0.55 | Reduce 0.23% | <0.01 | $70.29 | $976,912,772 | SEC |
| 2024 Q2 | 13,930,493 | 0.69 | Reduce 0.45% | <0.01 | $82.33 | $1,146,897,489 | SEC |
| 2024 Q1 | 13,992,943 | 0.71 | Reduce 0.01% | <0.01 | $87.34 | $1,222,143,642 | SEC |
| 2023 Q4 | 13,994,063 | 0.86 | Reduce 1.13% | <0.01 | $96.42 | $1,349,307,554 | SEC |
| 2023 Q3 | 14,153,503 | 0.85 | Reduce 0.96% | <0.01 | $88.48 | $1,252,301,945 | SEC |
| 2023 Q2 | 14,290,303 | 0.83 | Reduce 0.27% | <0.01 | $86.68 | $1,238,683,464 | SEC |
| 2023 Q1 | 14,329,313 | 0.95 | Reduce 0.38% | <0.01 | $97.24 | $1,393,382,396 | SEC |
| 2022 Q4 | 14,383,663 | 1.03 | Reduce 2.64% | 0.03 | $103.49 | $1,488,565,284 | SEC |
| 2022 Q3 | 14,773,963 | 0.95 | Reduce 1.55% | 0.01 | $84.77 | $1,252,389,000 | SEC |
| 2022 Q2 | 15,007,063 | 0.86 | Reduce 0.19% | <0.01 | $82.87 | $1,243,635,000 | SEC |
| 2022 Q1 | 15,034,999 | 0.71 | Add 1.42% | <0.01 | $77.10 | $1,159,198,000 | SEC |
| 2021 Q4 | 14,825,049 | 0.81 | Add 0.04% | <0.01 | $88.35 | $1,309,793,000 | SEC |
| 2021 Q3 | 14,818,582 | 0.75 | Add 5.08% | 0.04 | $77.29 | $1,145,328,000 | SEC |
| 2021 Q2 | 14,102,097 | 0.77 | Add 18.96% | 0.12 | $83.44 | $1,176,679,000 | SEC |
| 2021 Q1 | 11,854,308 | 0.64 | Add 21.00% | 0.11 | $75.51 | $895,119,000 | SEC |
| 2020 Q4 | 9,796,924 | 0.68 | Add 26.90% | 0.14 | $87.69 | $859,092,000 | SEC |
| 2020 Q3 | 7,720,223 | 0.54 | Add 113.52% | 0.29 | $76.08 | $587,355,000 | SEC |
| 2020 Q2 | 3,615,740 | 0.41 | Reduce 8.29% | 0.03 | $123.34 | $445,965,000 | SEC |
| 2020 Q1 | 3,942,508 | 0.36 | Reduce 10.18% | 0.03 | $84.50 | $333,142,000 | SEC |
| 2019 Q4 | 4,389,515 | 0.29 | Buy | 0.29 | $84.55 | $371,133,000 | SEC |